NEONATAL CHOLESTASIS

NEONATAL CHOLESTASIS was reported 84 times

NEONATAL CHOLESTASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 6 0.0019
1 Lipid Emulsion [EPC] 2 0.0008
2 Penem Antibacterial [EPC] 7 0.0002
3 Glycopeptide Antibacterial [EPC] 12 0.0002
4 Lipid-based Polyene Antifungal [EPC] 2 0.0002
5 Bile Acid [EPC] 3 0.0001
6 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
7 Nitroimidazole Antimicrobial [EPC] 8 0.0001
8 Vitamin K [EPC] 1 0.0001
9 Aminoglycoside Antibacterial [EPC] 4 0.0001
10 Protease Inhibitor [EPC] 3 0.0001
11 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
12 Azole Antifungal [EPC] 8 0.0001
13 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
14 Polyene Antifungal [EPC] 2 0.0000
15 Mood Stabilizer [EPC] 5 0.0000
16 Insulin [EPC] 1 0.0000
17 Leukocyte Growth Factor [EPC] 3 0.0000
18 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
19 Purine Antimetabolite [EPC] 2 0.0000
20 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
21 Anti-epileptic Agent [EPC] 4 0.0000
22 Loop Diuretic [EPC] 8 0.0000
23 Alkylating Drug [EPC] 4 0.0000
24 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
25 Cardiac Glycoside [EPC] 1 0.0000
26 HER2/neu Receptor Antagonist [EPC] 1 0.0000
27 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
28 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
29 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
30 Proton Pump Inhibitor [EPC] 5 0.0000
31 Corticosteroid [EPC] 9 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
33 Aldosterone Antagonist [EPC] 1 0.0000
34 Benzodiazepine [EPC] 3 0.0000
35 Platelet Aggregation Inhibitor [EPC] 2 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
37 Tumor Necrosis Factor Blocker [EPC] 1 0.0000